Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Completed · Phase 2

Conditions studied: Kidney Cancer, Melanoma (Skin), Metastatic Cancer, Ovarian Cancer, Sarcoma

In brief

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients with newly diagnosed brain metastases from kidney cancer, melanoma, or sarcoma.

Key facts

Study ID

NCT00003308

Run by

Eastern Cooperative Oncology Group

Starts

1999-02-02

Last updated by the study team

2023-06-22

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Iowa Methodist Medical Center — Des Moines, Iowa, United States
• Mercy Medical Center — Des Moines, Iowa, United States
• Iowa Lutheran Hospital — Des Moines, Iowa, United States
• CCOP - Kalamazoo — Kalamazoo, Michigan, United States
• Alegent Health-Midlands Community Hospital — Papillion, Nebraska, United States
• MBCCOP - University of New Mexico HSC — Albuquerque, New Mexico, United States
• Ireland Cancer Center — Cleveland, Ohio, United States
• Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States
• CCOP - St. Vincent Hospital Cancer Center, Green Bay — Green Bay, Wisconsin, United States
• Veterans Affairs Medical Center - Madison — Madison, Wisconsin, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States
• Westmead Hospital — Westmead, New South Wales, Australia
• Instituto de Enfermedades Neoplasicas — Lima, Peru
• San Juan City Hospital — San Juan, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.